CAS: 1883510-31-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
ML327 REF: AN-AG01EB2BCAS: 1883510-31-3 | 97% | 131.00 €~461.00 € | Thu 02 May 24 | |
ML327 REF: TM-T4252CAS: 1883510-31-3 | 99.48% | 49.00 €~791.00 € | Wed 08 May 24 | |
ML327 REF: 3D-IAD51031CAS: 1883510-31-3 | Min. 95% | To inquire | Wed 12 Jun 24 |
Ref: AN-AG01EB2B
1mg | 131.00 € | |
25mg | 170.00 € | |
50mg | 205.00 € | |
100mg | 461.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
ML327
CAS:1883510-31-3
ML327 is a MYC blocker. ML327 can also de-repress E-cadherin transcription and reverse Epithelial-to-Mesenchymal Transition …
Formula:
C19H18N4O4
Purity:
99.48%
Color and Shape:
Solid
Molecular weight:
366.37
Ref: TM-T4252
1mg | 49.00 € | |
5mg | 109.00 € | |
10mg | 171.00 € | |
25mg | 346.00 € | |
50mg | 555.00 € | |
100mg | 791.00 € | |
1ml*10 (DMSO) | 115.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
ML327
CAS:1883510-31-3
ML327 is a small molecule that has been shown to inhibit the growth of cancer …
Formula:
C19H18N4O4
Purity:
Min. 95%
Molecular weight:
366.37 g/mol
Ref: 3D-IAD51031
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Wednesday 12 Jun 2024